1Esholdt IH. Incontinentia pigmenti [J]. Nord Med, 1994,109 (2):58-60.
2Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology [J]. J Am Acad Dermatol, 2002, 47(2): 169-187.
3Carney RG.Incontinentia pigmenti.A world statistical analysis[J].Arch Dermatol,1976,112(4): 535-542.
4Landy SJ,Donnai D.Incontinentia pigmenti (Bloch-Sulzberger syndrome)[J].J Med Genet,1993,30(1): 53-59.
5The International Incontinentia Pigmenti (IP) Consortium.Genomic rearrangement in NEMO impairs NF-kappa B activation and is a cause of incontinentia pigmenti[J].Nature,2000,405(6785): 466-472.
7Berlin AL,Paller AS,Chan LS.Incontinentia pigmenti:a review and update on the molecular basis of pathophysiology[J].J Am Acad Dermatol,2002,47(2):169-187.
